eloquently show that endogenous production of the gasotransmitter, H 2 S, by airway epithelial cells significantly contributes to hypoxiainduced inhibition of epithelial sodium transport, specifically by inhibiting Na ϩ /K ϩ -ATPase activity. Transepithelial sodium absorption in the respiratory tract is a crucial process for the maintenance of the volume and composition of epithelial lining fluid, and its disruption is associated with lung diseases, such as pulmonary edema (hypoabsorption) or cystic fibrosis (hyperabsorption). The mechanisms by which the epithelium can sense changes in oxygen and how they, in turn, lead to aberrant fluid movement continues to interest researchers in this field. H 2 S is produced by amino acid metabolism, but it is rapidly degraded to sulfate by mitochondria in the presence of oxygen. Under hypoxic conditions, H 2 S concentrations have the potential to act as physiological effectors on numerous aspects of cellular function. Previously, these authors have demonstrated that exogenously applied H 2 S impairs airway epithelial sodium transport in an airway epithelial cell line (2) and in native distal lung preparations from Xenopus laevis (3) . Given the similar effects of hypoxia and H 2 S on transepithelial sodium absorption, as well as the increase in the concentration of H 2 S under hypoxic conditions, the authors sought to understand the role played by H 2 S as a physiological effector of hypoxia in epithelial cells. This paper advances the field by showing that hypoxia induces physiologically significant endogenous concentrations of H 2 S that are capable of inhibiting basolateral sodium movement by Na ϩ /K ϩ -ATPase through an unknown mechanism, restricting the electrochemical driving force for apical sodium entry via ENaC, which may lead to impaired transepithelial sodium absorption.
Questions arising from this study are whether this is a direct interaction with the pump or an indirect inhibition, for example, via alteration of basolateral K ϩ channels (2, 3) , and what the chemical basis for the observed effects of H 2 S is, i.e., is H 2 S present in its gas form or (more likely) in its anionic form HS Ϫ ? H 2 S/HS Ϫ may target cysteine residues by persulfidation due to the addition of HS Ϫ to thiolate or a sulfenic group to differentially affect protein function (4). H 2 S may even mediate its effects through interactions with another major gasotransmitter, nitric oxide (6), which the authors have previously shown can impair airway epithelial sodium reabsorption by interfering with the activity of the Na ϩ /K ϩ -ATPase (1). What are the physiological concentrations of H 2 S? The concentration of H 2 S that can be generated in vivo remains a controversial subject compounded by inaccuracies in the methods applied to measuring H 2 S (10), but physiologically significant concentrations in the respiratory tract are only likely to occur under hypoxic conditions. In other tissues, the capacity to degrade H 2 S is quite large (8) (which seems appropriate, since H 2 S is toxic at higher concentrations), and so the suggestion by the authors that H 2 S may inhibit transepithelial sodium transport and increase the alveolar lining fluid to enhance mucociliary transport in the presence of infectious agents that produce H 2 S seems unlikely, unless hypoxia is also present to inhibit the degradation of H 2 S.
As noted above, the regulation of H 2 S is a little odd. Many signaling molecules are regulated at the level of production. The signaling molecule, the product, provides negative feedback and inhibits its own production. H 2 S, on the other hand, is produced in abundance (as shown so effectively by the authors when they inhibited the synthetic enzymes to block the effects of H 2 S), and regulated instead by oxygen-dependent degradation of H 2 S by mitochondria. It is interesting that hypoxia-inducible factor-1␣ (HIF-1␣) is similarly regulated by degradation, and this degradation also originates from an oxygen-dependent process; hydroxylation of proline or asparagine within HIF-1␣, which targets the protein for proteolytic degradation (12) . This strategy is logical for hypoxic activation in any second messenger system in which oxygen is not required for second messenger production, but is required for degradation and is rate limiting by virtue of a relatively high K m for oxygen in one or more of the degradative enzymes. Circumstances that exist for both H 2 S and HIF-1␣.
These findings raise the question: could H 2 S be considered as an oxygen sensor in the respiratory epithelium rather than simply an effector or mediator under hypoxic conditions? H 2 S may be considered an oxygen sensor through its inhibition of oxidative phosphorylation or due to the inverse metabolic relationship between oxygen availability and oxygen-dependent degradation of endogenous H 2 S (9). This new role of H 2 S as an oxygen sensor has already been discussed for a variety of tissues, including the carotid body (5, 11) , but is likely to remain a somewhat controversial hypothesis for the respiratory epithelium due to the relatively limited data on H 2 S in the lung. Moreover, there is no requirement for oxygen in the interaction of H 2 S with its targets. It seems more appropriate to see the mitochondria and the initial oxygen-requiring step in the degradation of H 2 S by the membrane-bound sulfide:quinone oxidoreductase as the sensor in alveolar epithelial cells and likely in the carotid body. Thus, the function of H 2 S as a downstream effector of homeostatic regulation, which Krause et al. (7) have amply demonstrated for transepithelial sodium transport, may generate more interest for future research.
